Gilead Sciences Inc. Q3 Profit Decreases, but beats estimates

Gilead Sciences Inc. (GILD) reported earnings for third quarter that decreased from last year but beat the Street estimates.

The company's bottom line totaled $1.79 billion, or $1.42 per share. This compares with $2.59 billion, or $2.05 per share, in last year's third quarter.

Excluding items, Gilead Sciences Inc. reported adjusted earnings of $2.39 billion or $1.90 per share for the period.

Analysts on average had expected the company to earn $1.43 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 5.1% to $7.04 billion from $7.42 billion last year.

Gilead Sciences Inc. earnings at a glance (GAAP) :

-Earnings (Q3): $1.79 Bln. vs. $2.59 Bln. last year.
-EPS (Q3): $1.42 vs. $2.05 last year.
-Analyst Estimates: $1.43
-Revenue (Q3): $7.04 Bln vs. $7.42 Bln last year.

Full year EPS guidance: $6.95 - $7.15

For comments and feedback contact: editorial@rttnews.com

Follow RTT